GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A teenage patient has become the first in the UK, a hospital said, to receive what medics call a ground-breaking new drug for ...

A network meta-analysis reveals age-dependent variations in efficacy of popular diabetes drugs, with SGLT2 inhibitors showing ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Dr Joyce Huang will be joined by Dr Emma Mead to discuss the ways we’re widening the search for new dementia treatments.

The study reveals SGLT-2is are linked to fewer COPD exacerbations in type 2 diabetes, suggesting a need for further clinical ...

Groundbreaking research exposes how diabetes damages kidneys, offering hope through early detection and innovative prevention ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...